KLRS

VAN BEEK JEROEN B

Known title: Chief Commercial OfficerCIK: 0001743662

Associated companies

AI Market Commentary

AI-generatedAll commentary →

Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.

September 30, 2026

Kalaris Therapeutics Moves in Pre-Market Amid Low RSI. Kalaris Therapeutics was highlighted in a roundup of health care stocks moving in Wednesday's pre-market session. The stock is currently trading near its 52-week low, with the RSI indicating oversold conditions. Analysts maintain a wide range of price targets for the company, reflecting varying views on its future performance.

this person other insiders at KLRS

Transaction History

KLRS▼ Sell$121K
KLRS▼ Sell$300K
KLRS▼ Sell$105K
KLRS▼ Sell$2K
KLRS▼ Sell$10K
KLRS▼ Sell$4K
KLRS▼ Sell$129K
KLRS▲ Buy$0
KLRS▼ Sell$6K
KLRS▲ Buy$0
KLRS▼ Sell$2K
KLRS▼ Sell$67K
KLRS▼ Sell$6K
KLRS▼ Sell$5K
KLRS▼ Sell$128K
KLRS▼ Sell$41K
KLRS▲ Buy$0
KLRS▼ Sell$9K
KLRS▼ Sell$321K
KLRS▼ Sell$86K
KLRS▼ Sell$306K
KLRS▼ Sell$25K
KLRS▼ Sell$148K
KLRS▼ Sell$10K
KLRS▼ Sell$271K
KLRS▼ Sell$12K
KLRS▼ Sell$347K
KLRS▼ Sell$19K
KLRS▼ Sell$603K

We use analytics to understand how market-wall is used. No personal data is sold.